PERRIGO HOLDINGS UNLIMITED COMPANY

Perrigo Holdings Unlimited Company is a global health-and-wellness organisation dedicated to making lives better through trusted, self-care solutions that are accessible to all. Building on a heritage that dates back to 1887, Perrigo develops and manufactures a broad range of over-the-counter products, including ibuprofen and acetaminophen tablets, allergy-relief loratadine, digestive aids such as famotidine and omeprazole, as well as specialised items like minoxidil hair-regrowth solution, nicotine lozenges and personal lubricants. Each product is formulated without genetically engineered ingredients, offering consumers reliable alternatives to well-known brand equivalents.

Beyond its product portfolio, Perrigo places corporate responsibility at the heart of its operations. Through the Perrigo Foundation, the company has contributed more than €30 million in charitable donations and over €19 million in product donations over the past decade, supporting education, healthcare access and community well-being. This commitment to integrity, quality manufacturing and community investment underpins Perrigo's vision to provide the best and its purpose of improving everyday health for people everywhere.